AvePoint, Inc. Files Definitive Proxy Statement (DEF 14A)

Ticker: AVPT · Form: DEF 14A · Filed: Mar 19, 2024 · CIK: 1777921

Avepoint, Inc. DEF 14A Filing Summary
FieldDetail
CompanyAvepoint, Inc. (AVPT)
Form TypeDEF 14A
Filed DateMar 19, 2024
Risk Levellow
Pages16
Reading Time19 min
Sentimentneutral

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, AvePoint, Executive Compensation, Corporate Governance

TL;DR

<b>AvePoint, Inc. has filed its Definitive Proxy Statement (DEF 14A) for the fiscal year ending December 31, 2023, detailing executive compensation and corporate governance.</b>

AI Summary

AvePoint, Inc. (AVPT) filed a Proxy Statement (DEF 14A) with the SEC on March 19, 2024. AvePoint, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 19, 2024. The filing covers the fiscal year ending December 31, 2023. The company's principal executive offices are located at 525 Washington Blvd, Suite 1400, Jersey City, NJ 07310. The filing includes information related to executive compensation for the years 2021, 2022, and 2023. AvePoint, Inc. was formerly known as Apex Technology Acquisition Corp, with a name change date of May 28, 2019.

Why It Matters

For investors and stakeholders tracking AvePoint, Inc., this filing contains several important signals. This DEF 14A filing is crucial for shareholders as it outlines proposals to be voted on at the annual meeting, including the election of directors and executive compensation matters. Understanding the executive compensation details and any changes from prior years provides insight into the company's financial health and management's alignment with shareholder interests.

Risk Assessment

Risk Level: low — AvePoint, Inc. shows low risk based on this filing. The filing is a routine DEF 14A, indicating standard corporate governance procedures rather than immediate financial distress or significant operational changes.

Analyst Insight

Shareholders should review the proxy statement to understand executive compensation, director nominations, and other voting matters before the annual meeting.

Key Numbers

  • 2023-12-31 — Fiscal Year End (Reporting period)
  • 2024-03-19 — Filing Date (Date of submission)
  • 2024-05-07 — Period of Report (Date for which the report is filed)

Key Players & Entities

  • AvePoint, Inc. (company) — Filer name
  • Apex Technology Acquisition Corp (company) — Former company name
  • 2024-03-19 (date) — Filing date
  • 2024-05-07 (date) — Period of report
  • 2023-12-31 (date) — Fiscal year end
  • 525 Washington Blvd, Suite 1400, Jersey City, NJ 07310 (address) — Business address
  • 201-793-1111 (phone) — Business phone
  • 2019-05-28 (date) — Date of name change

FAQ

When did AvePoint, Inc. file this DEF 14A?

AvePoint, Inc. filed this Proxy Statement (DEF 14A) with the SEC on March 19, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by AvePoint, Inc. (AVPT).

Where can I read the original DEF 14A filing from AvePoint, Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by AvePoint, Inc..

What are the key takeaways from AvePoint, Inc.'s DEF 14A?

AvePoint, Inc. filed this DEF 14A on March 19, 2024. Key takeaways: AvePoint, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 19, 2024.. The filing covers the fiscal year ending December 31, 2023.. The company's principal executive offices are located at 525 Washington Blvd, Suite 1400, Jersey City, NJ 07310..

Is AvePoint, Inc. a risky investment based on this filing?

Based on this DEF 14A, AvePoint, Inc. presents a relatively low-risk profile. The filing is a routine DEF 14A, indicating standard corporate governance procedures rather than immediate financial distress or significant operational changes.

What should investors do after reading AvePoint, Inc.'s DEF 14A?

Shareholders should review the proxy statement to understand executive compensation, director nominations, and other voting matters before the annual meeting. The overall sentiment from this filing is neutral.

How does AvePoint, Inc. compare to its industry peers?

AvePoint operates in the software industry, specifically focusing on data management and protection solutions for cloud environments.

Are there regulatory concerns for AvePoint, Inc.?

The filing is made under the Securities Exchange Act of 1934, which governs the reporting requirements for public companies.

Industry Context

AvePoint operates in the software industry, specifically focusing on data management and protection solutions for cloud environments.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, which governs the reporting requirements for public companies.

What Investors Should Do

  1. Review the detailed executive compensation breakdown for Named Executive Officers (NEOs) and Principal Executive Officer (PEO).
  2. Examine the proposals to be voted on at the upcoming shareholder meeting, including director elections and advisory votes on executive compensation.
  3. Note any changes in corporate governance practices or policies outlined in the filing.

Key Dates

  • 2024-03-19: Filing Date — Definitive Proxy Statement (DEF 14A) filed.
  • 2024-05-07: Period of Report — The period for which the proxy statement is relevant.
  • 2023-12-31: Fiscal Year End — The end of the fiscal year covered by the filing.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard annual disclosure for public companies regarding their annual meeting of shareholders and related matters.

Filing Stats: 4,733 words · 19 min read · ~16 pages · Grade level 12.7 · Accepted 2024-03-19 12:50:58

Filing Documents

Business

Business The election of the two Class III director nominees named in this Proxy Statement; The approval, on a non-binding advisory basis, of the compensation paid to our named executive officers ("say-on-pay vote"); To vote, on a non-binding advisory basis, on the frequency of holding future say-on-pay votes; The ratification of the selection of Deloitte & Touch LLP as our independent auditor for fiscal year 2024; The approval of the adoption of the Third Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions for exculpation of officers; and Such other business that may properly come before stockholders at the Annual Meeting. Address of Corporate Offices Corporate Headquarters: 525 Washington Blvd., Ste. 1400, Jersey City, New Jersey 07310 Primary Operations Center: 901 East Byrd Street, Ste. 900, Richmond, Virginia 23219 Meeting Details See Proxy Summary on Page 1 – Information About the Meeting for details. Important notice regarding the availability of proxy materials for the Annual Meeting to be held on May 7, 2024. Our 2024 Proxy Statement and 2023 Annual Report to Stockholders are available at ir.avepoint.com. By Order of the Board of Directors Brian Michael Brown, Esq. Chief Legal and Compliance Officer, and Secretary Richmond, Virginia March 19, 2024 Table of Contents Table of Contents Page Proxy Summary 1 Voting Matters and Vote Recommendations 1 Board of Directors 2 Questions And Answers About These Proxy Materials and Voting 3

Security Ownership

Security Ownership 9 Election of Directors (Proposal 1) 11 Nominees for Election as Directors 11 Approval of Nominees 11 Information About Nominees and Continuing Directors 12 Directors For Election into Class III at the 2024 Annual Meeting of Stockholders 12 Directors in Class I Whose Terms Expire in 2025 12 Directors in Class II Whose Terms Expire in 2026 13 Board Diversity 14 Corporate Governance 15 Board of Directors 15 Board Leadership Structure 15 Board Committees 17 Board Risk Oversight 18 Environmental, Social and Governance Matters 19 Compensation Committee Interlocks and Insider Participation 23 Director Nominations Policy 23 Communications with the Board of Directors, Reporting Questionable Accounting, Internal Accounting Controls and Auditing Matters 24 Stockholder Engagement 24 Availability of Code of Conduct and Ethics, Bylaws, Corporate Governance Guidelines, and Committee Charters 24 Non-Employee Director Compensation 25 Anti-Hedging and Anti-Pledging within Insider Trading Policy 26 Named Executive Officers 27 Compensation Discussion and Analysis 27 Introduction 27 2023 Say-on-Pay Results and Considerations 28 Compensation Philosophy and Objectives 28 How Do We Determine Executive Pay? 29 Elements of Executive Compensation 30 Perquisites 33 Additional Information on our Program 33 i Table of Contents Report of the Compensation Committee of the Board of Directors of AvePoint, Inc. 34 Summary Compensation Table 34 Grants of Plan Based Awards in Fiscal Year 2023 35 Outstanding Equity Awards at Fiscal-Year End 36 Option Exercises and Stock Vested in Fiscal Year 2023 37 Equity Compensation Plan Information 40 CEO Pay Ratio 40 Pay Versus Performance Disclosure 41 The Company ' s Compensation Policies and Practices as They Relate to Risk 44 Advisory Vote on Executive Compensation (Proposal 2) 44

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.